PDF herunterladen
Am J Perinatol
DOI: 10.1055/a-1799-5714
Original Article

Risk Factors for Measles Nonimmunity in Rubella-Immune Pregnant Patients

Elias Kassir 
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Kerry Holliman
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Masaru Negi
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Hai-Lang Duong
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Megha D. Tandel
2   Department of Urology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Lorna Kwan
2   Department of Urology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Gwendolyn Lee 
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Neil S. Silverman
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Rashmi R. Rao
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
,
Christina S. Han
1   Department of Obstetrics and Gynecology, University of California, Los Angeles (UCLA), Los Angeles, California
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Objectives Measles immunity testing, unlike that for rubella, is not currently part of prenatal screening even though immunity to both is conferred by the measles–mumps–rubella (MMR) vaccine. Although endemic transmission of measles was declared eliminated in the United States in 2001, outbreaks have continued to occur. Given the risks associated with measles infection during pregnancy, we sought to identify risk factors for measles nonimmunity (MNI) in rubella-immune (RI) pregnant individuals.

Methods We performed a retrospective observational cross-sectional study of patients receiving prenatal care and delivering at two university hospitals and a county hospital in Southern California from April 1, 2019 to February 1, 2021. Inclusion criteria were pregnant individuals ≥18 years old who had serological testing for rubella and measles during pregnancy. Demographic data were extracted from electronic medical records, including results of serological testing and chronic medical conditions. All subjects were rubella immune, and we compared measles-immune (MI) with MNI groups.

Results In total, 1,813 RI individuals were identified, with 1,467 (81%) MI and 346 (19%) MNI individuals. Variables associated with an increased risk of MNI included having public health insurance (adjusted relative risk [aRR]: 1.56; 95% confidence interval [CI]: 1.24, 1.97) and Hispanic ethnicity (aRR: 1.37; 95% CI: 1.06, 1.78). Black race was associated with a decreased risk of MNI (aRR: 0.52; 95% CI: 0.29, 0.91). Birth year before 1989 demonstrated a trend toward increased risk of MNI, but this did not reach statistical significance (aRR 1.23; 95% CI: 1.00, 1.52). No differences were seen between the two groups for medical comorbidities.

Conclusion Our study is the first to demonstrate risk factors for measles MNI in patients with documented rubella immunity. In the absence of universal measles serological screening recommendations, the risk factors identified could help guide clinicians in selective screening for those at risk of needing postpartum MMR vaccination.

Key Points

  • The rate of measles nonimmunity is higher than previously reported.

  • Hispanic ethnicity and use of public insurance are risk factors for measles nonimmunity.

  • The current recommendation for history-based screening for measles immunity is likely insufficient.

Keywords

measles - rubella - prenatal care - vaccine - MMR

Note

This study was presented via oral presentation at the Infectious Disease Society of Obstetrics and Gynecology 2021 Annual Conference in July 2021.




Publikationsverlauf

Eingereicht: 25. September 2021

Angenommen: 11. März 2022

Accepted Manuscript online:
15. März 2022

Artikel online veröffentlicht:
31. Mai 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers 2016; 2: 16049
    CrossrefPubMedGoogle Scholar
  • 2 Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L. Measles in pregnancy: a descriptive study of 58 cases. Obstet Gynecol 1993; 82 (05) 797-801
    PubMedGoogle Scholar
  • 3 McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62 (RR-04): 1-34
    PubMedGoogle Scholar
  • 4 Plans P, de Ory F, Campins M. et al. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Eur J Clin Microbiol Infect Dis 2015; 34 (06) 1161-1171
    CrossrefPubMedGoogle Scholar
  • 5 Patel M, Lee AD, Clemmons NS. et al. National update on measles cases and outbreaks – United States January 1–October 1, 2019. MMWR Morb Mortal Wkly Rep 2019; 68 (40) 893-896
    CrossrefPubMedGoogle Scholar
  • 6 Kachikis A, Oler E, Shree R, Waldorf KAdams, Hitti J, Eckert LO.. Measles and the MMR vaccine: recommendations around pregnancy, including the periconception and postpartum periods: obstetric consensus statement. University of Washington. revised April 2019
    PubMedGoogle Scholar
  • 7 Kennedy CM, Burns BA, Ault KA. Does rubella immunity predict measles immunity? A serosurvey of pregnant women. Infect Dis Obstet Gynecol 2006; 2006: 13890
    CrossrefPubMedGoogle Scholar
  • 8 Lebo EJ, Kruszon-Moran DM, Marin M. et al. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis 2015; 2 (01) ofv006
    CrossrefPubMedGoogle Scholar
  • 9 Shirts BH, Welch RJ, Couturier MR. Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination. Clin Vaccine Immunol 2013; 20 (03) 443-445
    CrossrefPubMedGoogle Scholar
  • 10 Hirschberg CI, Limaye M, Roman A. et al. A modern measles outbreak: understanding maternal immunity and impact on postpartum vaccination uptake. Am J Obstet Gynecol MFM 2021; 3 (03) 100309
    CrossrefPubMedGoogle Scholar
  • 11 Gastañaduy PA, Budd J, Fisher N. et al. A measles outbreak in an underimmunized Amish community in Ohio. N Engl J Med 2016; 375 (14) 1343-1354
    CrossrefPubMedGoogle Scholar
  • 12 Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS. Centers for Disease Control and Prevention (CDC). Measles − United States, January 4−April 2, 2015. MMWR Morb Mortal Wkly Rep 2015; 64 (14) 373-376
    PubMedGoogle Scholar
  • 13 Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned. J Infect Dis 2004; 189 (Suppl. 01) S243-S250
    PubMedGoogle Scholar
  • 14 De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151 (11) 1039-1048 , discussion 1049–1052
    CrossrefPubMedGoogle Scholar
  • 15 Blakeney EL, Herting JR, Bekemeier B, Zierler BK. Social determinants of health and disparities in prenatal care utilization during the Great Recession period 2005-2010. BMC Pregnancy Childbirth 2019; 19 (01) 390
    CrossrefPubMedGoogle Scholar
  • 16 Kim MK, Lee SM, Bae SH. et al. Socioeconomic status can affect pregnancy outcomes and complications, even with a universal healthcare system. Int J Equity Health 2018; 17 (01) 2
    CrossrefPubMedGoogle Scholar
  • 17 Immigrant, Refugee and Migrant Health Frequently Asked Questions. Centers for Disease Control and Prevention. 2012 March 29. Accessed July 13, 2021 https://www.cdc.gov/immigrantrefugeehealth/laws-regs/vaccination-immigration/revised-vaccination-immigration-faq.html#whatvaccines
    PubMedGoogle Scholar
  • 18 Painter JE, Viana De O Mesquita S, Jimenez L, Avila AA, Sutter CJ, Sutter R. Vaccine-related attitudes and decision-making among uninsured, Latin American immigrant mothers of adolescent daughters: a qualitative study. Hum Vaccin Immunother 2019; 15 (01) 121-133
    CrossrefPubMedGoogle Scholar
  • 19 Latinos in California, Texas, New York, Florida, and New Jersey. Pew Research Center. 2004 March 19. Accessed July 13, 2021 https://www.pewresearch.org/hispanic/2004/03/19/latinos-in-california-texas-new-york-florida-and-new-jersey/
    PubMedGoogle Scholar
  • 20 van Boven M, Kretzschmar M, Wallinga J, O'Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface 2010; 7 (52) 1537-1544
    CrossrefPubMedGoogle Scholar